A2D (p.Ala2Asp) variant of CDK9 (Cyclin-dependent kinase 9)
A2D (p.Ala2Asp) in CDK9 (Cyclin-dependent kinase 9) is a protein-truncating change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.49 / 1. The record also includes population frequency data, published literature, and structural context.
A2D (p.Ala2Asp) variant details
- p.Ala2Asp
- gnomAD 9-127785815-ACCCC
- Frameshift
- Variant Prioritization Score for Impact Estimate 0.49
- CADD 18.80
- Population evidence available
- Structural context available
- Literature evidence available